Moe GW - Search Results

1

ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada.

Parker AB, Azevedo ER, Baird MG, Smith SJ, Arnold JM, Humen DP, Moe GW, Parker JO, Butt RW, Parker JD. Parker AB, et al. Among authors: moe gw. Am Heart J. 1999 Nov;138(5 Pt 1):843-8. doi: 10.1016/s0002-8703(99)70008-6. Am Heart J. 1999. PMID: 10539814 Clinical Trial.

2

Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.

Moe GW, Canepa-Anson R, Armstrong PW. Moe GW, et al. J Cardiovasc Pharmacol. 1992 May;19(5):691-700. J Cardiovasc Pharmacol. 1992. PMID: 1381766

3

Response of atrial natriuretic factor to postural change in patients with heart failure versus subjects with normal hemodynamics.

Moe GW, Canepa-Anson R, Howard RJ, Armstrong PW. Moe GW, et al. J Am Coll Cardiol. 1990 Sep;16(3):599-606. doi: 10.1016/0735-1097(90)90349-t. J Am Coll Cardiol. 1990. PMID: 2143766 Free article.

4

Intravenous nisoldipine in severe congestive heart failure.

Moe GW, Karlinsky SJ, Frankel D, Armstrong PW. Moe GW, et al. J Cardiovasc Pharmacol. 1988 Aug;12(2):160-6. doi: 10.1097/00005344-198808000-00006. J Cardiovasc Pharmacol. 1988. PMID: 2459547

5

Medical advances in the treatment of congestive heart failure.

Armstrong PW, Moe GW. Armstrong PW, et al. Among authors: moe gw. Circulation. 1993 Dec;88(6):2941-52. doi: 10.1161/01.cir.88.6.2941. Circulation. 1993. PMID: 7902784 Review.

6

Dual natriuretic peptide system in experimental heart failure.

Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Moe GW, et al. J Am Coll Cardiol. 1993 Sep;22(3):891-8. doi: 10.1016/0735-1097(93)90208-i. J Am Coll Cardiol. 1993. PMID: 8354829 Free article.

7

Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure.

Moe GW, Albernaz A, Naik GO, Kirchengast M, Stewart DJ. Moe GW, et al. Cardiovasc Res. 1998 Sep;39(3):571-9. doi: 10.1016/s0008-6363(98)00169-2. Cardiovasc Res. 1998. PMID: 9861299

8

Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan.

Moe GW, Rouleau JL, Charbonneau L, Proulx G, Arnold JM, Hall C, de Champlain J, Barr A, Sirois P, Packer M. Moe GW, et al. Am Heart J. 2000 Apr;139(4):587-95. doi: 10.1016/s0002-8703(00)90035-8. Am Heart J. 2000. PMID: 10740139 Clinical Trial.

9

On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada.

Johansen H, Strauss B, Arnold JM, Moe G, Liu P. Johansen H, et al. Can J Cardiol. 2003 Mar 31;19(4):430-5. Can J Cardiol. 2003. PMID: 12704491

10

The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure.

Khan A, Moe GW, Nili N, Rezaei E, Eskandarian M, Butany J, Strauss BH. Khan A, et al. Among authors: moe gw. J Am Coll Cardiol. 2004 Jan 7;43(1):68-76. doi: 10.1016/j.jacc.2003.07.030. J Am Coll Cardiol. 2004. PMID: 14715186 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters